135 related articles for article (PubMed ID: 38401774)
21. Herpesvirus infections in hematopoietic stem cell transplant recipients seropositive for human cytomegalovirus before transplantation.
Fan J; Jing M; Yang M; Xu L; Liang H; Huang Y; Yang R; Gui G; Wang H; Gong S; Wang J; Zhang X; Zhao H; Gao H; Dong H; Ma W; Hu J
Int J Infect Dis; 2016 May; 46():89-93. PubMed ID: 27057748
[TBL] [Abstract][Full Text] [Related]
22. New 4-Acyl-1-phenylaminocarbonyl-2-phenylpiperazine Derivatives as Potential Inhibitors of Adenovirus Infection. Synthesis, Biological Evaluation, and Structure-activity Relationships.
Sánchez-Céspedes J; Martínez-Aguado P; Vega-Holm M; Serna-Gallego A; Candela JI; Marrugal-Lorenzo JA; Pachón J; Iglesias-Guerra F; Vega-Pérez JM
J Med Chem; 2016 Jun; 59(11):5432-48. PubMed ID: 27195951
[TBL] [Abstract][Full Text] [Related]
23. Effect of everolimus-based drug regimens on CMV-specific T-cell functionality after renal transplantation: 12-month ATHENA subcohort-study results.
Hauser IA; Marx S; Sommerer C; Suwelack B; Dragun D; Witzke O; Lehner F; Schiedel C; Porstner M; Thaiss F; Neudörfl C; Falk CS; Nashan B; Sester M
Eur J Immunol; 2021 Apr; 51(4):943-955. PubMed ID: 33306229
[TBL] [Abstract][Full Text] [Related]
24. Sirolimus and low-dose tacrolimus with antibody induction in kidney transplantation: preliminary results of a pilot study.
Lawen J; Keough-Ryan T; Clase C; Kiberd B
Transplant Proc; 2001; 33(7-8):3223-5. PubMed ID: 11750382
[No Abstract] [Full Text] [Related]
25. Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art.
Campos AB; Ribeiro J; Boutolleau D; Sousa H
Rev Med Virol; 2016 May; 26(3):161-82. PubMed ID: 26990717
[TBL] [Abstract][Full Text] [Related]
26. Effect of immunosuppressive drugs on spontaneous DNA repair in human peripheral blood mononuclear cells.
Ori Y; Herman-Edelstein M; Zingerman B; Rozen-Zvi B; Gafter U; Malachi T; Gafter-Gvili A
Biomed Pharmacother; 2012 Sep; 66(6):409-13. PubMed ID: 22795807
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effects by combination of ganciclovir and tricin on human cytomegalovirus replication in vitro.
Yamada R; Suda H; Sadanari H; Matsubara K; Tuchida Y; Murayama T
Antiviral Res; 2016 Jan; 125():79-83. PubMed ID: 26640224
[TBL] [Abstract][Full Text] [Related]
28. Combination of immunosuppressive drugs leaves specific "fingerprint" on gene expression in vitro.
Rumberger B; Kreutz C; Nickel C; Klein M; Lagoutte S; Teschner S; Timmer J; Gerke P; Walz G; Donauer J
Immunopharmacol Immunotoxicol; 2009 Jun; 31(2):283-92. PubMed ID: 19235537
[TBL] [Abstract][Full Text] [Related]
29. The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate.
Perez-Simón JA; Martino R; Parody R; Cabrero M; Lopez-Corral L; Valcarcel D; Martinez C; Solano C; Vazquez L; Márquez-Malaver FJ; Sierra J; Caballero D
Haematologica; 2013 Apr; 98(4):526-32. PubMed ID: 23065527
[TBL] [Abstract][Full Text] [Related]
30. Cytomegalovirus disease in de novo kidney-transplant recipients: comparison of everolimus-based immunosuppression without prophylaxis with mycophenolic acid-based immunosuppression with prophylaxis.
Manière L; Noble J; Terrec F; Bennani HN; Chevallier E; Janbon B; Germi R; Bugnazet M; Imerzoukene F; Malvezzi P; Rostaing L; Jouve T
Int Urol Nephrol; 2021 Mar; 53(3):591-600. PubMed ID: 33058036
[TBL] [Abstract][Full Text] [Related]
31. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Cytomegalovirus Replication with Extended-Half-Life Synthetic Ozonides.
Wang Y; Mukhopadhyay R; Roy S; Kapoor A; Su YP; Charman SA; Chen G; Wu J; Wang X; Vennerstrom JL; Arav-Boger R
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373792
[TBL] [Abstract][Full Text] [Related]
33. Restriction of Human Cytomegalovirus Infection by Galectin-9.
Machala EA; Avdic S; Stern L; Zajonc DM; Benedict CA; Blyth E; Gottlieb DJ; Abendroth A; McSharry BP; Slobedman B
J Virol; 2019 Feb; 93(3):. PubMed ID: 30487283
[TBL] [Abstract][Full Text] [Related]
34. [Clinical and experimental study on antiviral activity of reduqing against human cytomegalovirus].
Xing W; Wen L; Dong J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Apr; 20(4):245-7. PubMed ID: 11789257
[TBL] [Abstract][Full Text] [Related]
35. Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein.
Mercorelli B; Luganini A; Celegato M; Palù G; Gribaudo G; Loregian A
Antiviral Res; 2018 Feb; 150():130-136. PubMed ID: 29274844
[TBL] [Abstract][Full Text] [Related]
36. Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance.
Piret J; Boivin G
Antiviral Res; 2019 Mar; 163():91-105. PubMed ID: 30690043
[TBL] [Abstract][Full Text] [Related]
37. Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses.
Tedesco-Silva H; Felipe C; Ferreira A; Cristelli M; Oliveira N; Sandes-Freitas T; Aguiar W; Campos E; Gerbase-DeLima M; Franco M; Medina-Pestana J
Am J Transplant; 2015 Oct; 15(10):2655-64. PubMed ID: 25988935
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of prednisolone and azathioprine on the development of human cytomegalovirus replication post liver transplantation.
Nebbia G; Mattes FM; Sabin CA; Samonakis D; Rolando N; Burroughs AK; Emery VC
Transplantation; 2007 Sep; 84(5):605-10. PubMed ID: 17876273
[TBL] [Abstract][Full Text] [Related]
39. Artemisone demonstrates synergistic antiviral activity in combination with approved and experimental drugs active against human cytomegalovirus.
Oiknine-Djian E; Bar-On S; Laskov I; Lantsberg D; Haynes RK; Panet A; Wolf DG
Antiviral Res; 2019 Dec; 172():104639. PubMed ID: 31654672
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial.
Saliba F; Duvoux C; Gugenheim J; Kamar N; Dharancy S; Salamé E; Neau-Cransac M; Durand F; Houssel-Debry P; Vanlemmens C; Pageaux G; Hardwigsen J; Eyraud D; Calmus Y; Di Giambattista F; Dumortier J; Conti F
Am J Transplant; 2017 Jul; 17(7):1843-1852. PubMed ID: 28133906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]